CAV1 and breast cancer: The mitochondrial-targeted superoxide dismutase 2(SOD2) is a potential inhibitor that can resist to oxidative stress and block the production of molecules that can nourish tumors, thereby effectively reversing the tumor-promoting phenotype of CAV-1 in breast cancer cells (27).